Ibotta Inc. IBTA 深 沪
已收盘 08-01 16:00:00 美东时间
34.73
-1.620
-4.46%
华盛通- 最 高36.335
- 今 开36.27
- 成交量 44.95万股
- 最 低 34.69
- 昨 收 36.35
- 总市值 9.88亿
- 52周最高 79.8017
- 市盈率 静 13.57
- 换手率 1.58%
- 52周最低 31.40
- 委 比 20.00%
- 总股本 2844.78万
- 历史最高 117.59
- 量 比 1.80
- 振 幅 4.53%
- 历史最低 31.40
- 每 手 1
- 风险率 13.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ibotta, Inc. Expands Share Repurchase Program Again
Ibotta, Inc. Class A ( ($IBTA) ) has provided an announcement. On June 9, 2025,...
06-10 18:41
Ibotta authorizes additional $100 million for share repurchase
Ibotta (NYSE:IBTA) has announced that its board has approved an increase to its share repurchase program, with authorization to purchase up to an additional aggregate of $100 million of the company’s ...
06-10 14:22
Contact The Gross Law Firm by June 16, 2025 Deadline to Join Class Action Against Ibotta, Inc.(IBTA)
NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class...
06-09 17:45
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
美股牛股 | 富乐客暴涨85.7%，获迪克体育用品拟24亿美元收购；“屯币股”NXTT再次飙升36%
富乐客暴涨85.7%，获迪克体育用品拟24亿美元收购；“屯币股”NXTT再次飙升36%，披露持有超5800比特币>>
05-16 20:08
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
What's Going On With Ibotta Stock Thursday?
Ibotta reported better-than-expected first-quarter financial results.
05-16 00:37
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
Gainers Token Cat (NASDAQ:TC) shares rose 13.3% to $0.85 during Thursday's pre...
05-15 20:09
Needham Maintains Buy on Ibotta, Raises Price Target to $70
Needham analyst Bernie McTernan maintains Ibotta (NYSE:IBTA) with a Buy and raises the price target from $60 to $70.
05-15 19:27
Ibotta shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.
Ibotta shares are trading higher after the company reported better-than-expecte...
05-15 04:14
